Cargando…
Thioperamide treats neonatal hypoxic-ischemic encephalopathy by postsynaptic H1 receptors
Thioperamide, a selective histamine H3 receptor antagonist, can increase histamine content in the brain, improve brain edema, and exert a neuroprotective effect. This study aimed to examine the mechanism of action of thioperamide during brain edema in a rat model of neonatal hypoxic-ischemic encepha...
Autores principales: | Jia, Feiyong, Du, Lin, Hao, Yunpeng, Liu, Shicheng, Li, Ning, Jiang, Huiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145950/ https://www.ncbi.nlm.nih.gov/pubmed/25206478 http://dx.doi.org/10.3969/j.issn.1673-5374.2013.19.009 |
Ejemplares similares
-
Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy
por: Ranjan, Amaresh K., et al.
Publicado: (2023) -
Language in Children with Neonatal Hypoxic-Ischemic Encephalopathy
por: Martinez, Chenia, et al.
Publicado: (2014) -
Whole Body Cooling for Infants with Hypoxic-Ischemic Encephalopathy
por: Mosalli, Rafat
Publicado: (2012) -
Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy
por: Gonzales-Portillo, Gabriel S., et al.
Publicado: (2014) -
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
por: Dixon, Brandon J., et al.
Publicado: (2015)